LALWANI NIKHIL (PRESIDENT & CEO) sold 13.6% of their position (55K shares) of ANI PHARMACEUTICALS INC on the open market
Open‑market sale worth $4.27M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/13/2026ACC: 0001822629-26-000011
DirectorOfficer· PRESIDENT & CEO
Since Sep 2020
-55K
Net shares
Net seller
$4.27M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
55K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−55K
Price / share
$77.57
Trade value
$4.27M
% of position
13.6%
5/11/2026
404.89K→349.89K
Total
Net shares
−55K
Net value
-$4.27M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/11/2026 | S · Sale | −55K | $77.57 | $4.27M | 13.6% | 404.89K | 349.89K |
| Total | −55K | -$4.27M | ||||||
Derivative Transactions0
No derivative transactions reported